High-throughput detection of clinically targetable alterations using next-generation sequencing

SUPPLEMENTARY MATERIALS AND METHODS
Qualification of DNA extracted from FFPE samples
Amplifiability of the gDNA extracted from FFPE samples is determined by quantitative PCR (qPCR) using the KAPA SYBR FAST Master Mix Universal (Kapa Biosystems, Wilmington, USA). FFPE DNA and a quality control template (QCT), that is a non-FFPE reference gDNA, called, are analysed in triplicate. qPCR was performed on a LightCycler 480 (Roche, Meylan, France) using the PCR program detailed on the Illumina's procedure, with acquisition of signals after the elongation step. For each sample, the quantification cycle (Cq) is determined. The average Cq for the QCT was then subtracted from the average Cq for each sample to obtain the ΔQc for each sample. Samples were then diluted according to the ΔQc and the Illumina's recommandations as follow:
-Samples with a ΔQc from -2.5 to -1.5 were diluted 16-fold -Samples with a ΔQc from -1.5 to -0.5 were diluted 8-fold -Samples with a ΔQc from -0.5 to 0.5 were diluted 4-fold -Samples with a ΔQc from 0.5 to 1.5 were diluted 2-fold -Samples with a ΔQc from 1.5 to 4 were not diluted -Samples with a ΔQc >4 that are normally not suitable for NGS analysis were not diluted
Filter criteria for variant calling
SNPs and short indels are identified using the somatic variant caller implemented in the SeqNext software (JSI Medical Systems, Ettenheim, Germany) according to the following criteria: (i) reads for which 60% of the bases have a quality score below Q20 were excluded from the analysis; (ii) only amplicons with a read depth of 100x or greater were used for variant calling; (iii) variants were called if they were present in both libraries with a mean VAF of 3% or greater. 
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